Thermo Fisher to acquire One Lambda

Thermo Fisher Scientific Inc. (NYSE:TMO) will acquire transplant diagnostics company One Lambda Inc. (Canoga Park, Calif.) for $925 million in cash. Thermo Fisher said One Lambda's portfolio of human leukocyte antigen (HLA) typing and antibody detection tests will complement Thermo Fisher's immunosuppressant monitoring assays. One Lambda had $182 million in 2011 revenue. Thermo Fisher had 2011 revenues of $11.7 billion. The deal is expected to close in 4Q12.

JPMorgan is advising Thermo Fisher, while Wilmer Cutler Pickering Hale and Dorr is legal counsel. Perella Weinberg is advising One Lambda, while Sheppard, Mullin, Richter & Hampton is legal advisor. Thermo Fisher was off $0.14 to $51.90 on Monday. ...